Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Citi on Nonfarm Payrolls: The US Dollar Is Welcoming a Favorable Environment for an Increase

Citi on Nonfarm Payrolls: The US Dollar Is Welcoming a Favorable Environment for an Increase

金十金十2026/06/05 13:44
Show original
Golden Ten Data reported on June 5th that US employment data exceeded expectations, strengthening the US dollar, while progress in US-Iran peace talks has stalled. The US Dollar Index is set to post its largest gain since April 8 on Friday; it is up 0.6% this week, likely to mark the biggest increase in three months. While other regions around the world are struggling with high energy prices caused by the Middle East conflict, US employment growth in May exceeded market expectations and the unemployment rate remained stable. This employment data has reinforced market expectations for a Federal Reserve rate hike. “This is a favorable environment for the US dollar to rise,” said Noah Buffam, strategist at Citi Capital Markets. “The data indicates that the US exceptionalism theory has stood the test, with economic rebound achieved while inflation remains above target levels.”
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) TROP2 ADC receives approval for new indication in China

According to information from Zhihu Finance APP, AstraZeneca (AZN.US) and Daiichi Sankyo (DSNKY.US) have announced that Datroway® (generic name: datopotamab deruxtecan for injection) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not suitable for PD-1/PD-L1 inhibitor therapies. Datopotamab deruxtecan is an antibody-drug conjugate (ADC) targeting TROP2, developed with proprietary technology by Daiichi Sankyo, and jointly developed and commercialized by AstraZeneca and Daiichi Sankyo.

智通财经•2026/10/08 08:46

Abu Dhabi National Oil Company invites bids for crude oil cargo shipments

Trader: Abu Dhabi National Oil Company issued a tender this week to sell crude oil for December loading or January delivery.

智通财经•2026/10/08 08:46

The Central Bank of Turkey conducts a 6-ton gold-for-lira weekly sell swap auction.

The Central Bank of Turkey conducted a one-week gold-for-lira sell swap auction using traditional methods, with a scale of 6 tons.

智通财经•2026/10/08 08:46
The Central Bank of Turkey conducts a 6-ton gold-for-lira weekly sell swap auction.

European Court of Auditors: EU debt continues to rise and may reach 1 trillion euros by 2027

On October 8 local time, the European Court of Auditors (ECA) released its 2025 annual report, expressing concerns over the continuous growth of EU debt. According to the report, by the end of 2025, the EU's debt had reached approximately 740 billion euros. The report also warns that this figure may further rise to 1 trillion euros by 2027. The ECA pointed out that the increase in EU debt is mainly related to aid for Ukraine, rising interest rates, defense spending, and the EU recovery fund. (CCTV)

智通财经•2026/10/08 08:36